Roth Capital Upgrades CymaBay Therapeutic (CBAY) to Buy May 12, 2020 07:26AM
Roth Capital Downgrades CymaBay Therapeutic (CBAy) to Neutral Nov 26, 2019 08:42AM
NetworkNewsBreaks – CymaBay Therapeutics, Inc. (NASDAQ: CBAY) Closes Underwritten Public Offering, Realizes Gross Proceeds of Approximately $115M Apr 5, 2019 10:58AM
CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Mar 11, 2019 12:05PM
CymaBay Therapeutics (CBAY) Prices 8M Common Stock Offering at $12.50/Share Mar 6, 2019 08:04AM


Mar 6, 2019 08:00AM CymaBay Announces Pricing of Public Offering of Common Stock
Mar 5, 2019 04:04PM CymaBay Therapeutics (CBAY) to Offer Common Stock
Mar 5, 2019 04:01PM CymaBay Announces Proposed Public Offering of Common Stock
Feb 1, 2018 04:01PM CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 30, 2018 08:03AM CymaBay Therapeutics (CBAY) Prices 11.6M Shares at $10.80
Jan 30, 2018 08:00AM CymaBay Announces Pricing of Public Offering of Common Stock
Jan 25, 2018 08:04AM Roth Capital Assumes CymaBay Therapeutic (CBAY) at Buy
Jan 4, 2017 09:29AM Pre-Open Stock Movers 01/04: (EVOK) (CBAY) (OCUL) Higher; (AGRX) (ACUR) (ENSG) Lower (more...)
Jan 3, 2017 05:50PM After-Hours Stock Movers 01/03: (CBAY) (SHAK) (CC) Higher; (AGRX) (ACUR) (TSLA) Lower (more...)
Sep 19, 2014 06:45AM Roth Capital Starts CymaBay Therapeutic (CBAY) at Buy
Jul 22, 2014 08:14AM CymaBay Therapeutics (CBAY) Prices 4M Follow-On at $5.50/Share